Key clinical point: A new draft guideline for the diagnosis and management of thrombocytopenic purpura (TTP) was released by the International Society on Thrombosis and Hemostasis (ISTH).
Major finding: For patients with immune TTP experiencing a first acute event, add corticosteroids to therapeutic plasma exchange. For immune TTP patients experiencing a relapse, add corticosteroids to therapeutic plasma exchang.
Study details: An international guideline for TTP.
Disclosures: The guideline was supported by ISTH. Fifty percent of the panel members had no or minimal conflict of interest; those with conflicts of interest abstained from voting on recommendations relevant to their conflicts.
Zheng XL et al. 2019 Sep 27. ISTH.org.